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1. Background 
 
Introduction 
 
Following the publication of the Association of Drug Action Teams 
report on Drug Related Deaths in January 2005, and in advance of 
the publication of the National Investigation into Drug Related 
Deaths Report, in May 2005 the Scottish Executive tasked a short-
life working group of the Scottish Advisory Committee on Drug 
Misuse (SACDM) to consider both reports and to develop 
recommendations regarding the framing of a policy response that 
would support a future reduction in drug related deaths in Scotland. 
 
A full list of the Membership of the SACDM Working Group is given 
in Appendix A. 
 
The remit of the SACDM Working Group was to: 
 
• Compile a set of practical recommendations based on the final 
report of the National Investigation into Drug Related Deaths 
in 2003, by 1 July 2005; 
 
• Take into account local solutions and ideas when determining 
the recommendations based on the final report of the 
Association of Drug Action Teams Drug Related Deaths 
Working Group; 
 
• Consider best practice from other regions; 
 
• Explore the future role of GPs in identifying ‘at risk’ cases; 
and 
 
• By 15 July 2005 produce a draft plan with a view to the 
Scottish Executive taking action to reduce drug related deaths 
in Scotland. 
 
 
The SACDM Working Group met for the first time on 25 April 2005 
to discuss key points raised in both reports, identify similarities and 
points of difference that would allow the development of 
recommendations with key action points in the most important 
areas that the reports had identified. It then met on 4 further 
occasions prior to publication of the report on 8 August 2005. 
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The National Investigation 
 
In 2003 the General Register Office for Scotland (GROS) reported 
the country’s highest ever annual number of drug related deaths, 
382 deaths during 2002 (GROS 2003). The Deputy Minister for 
Justice, Mr Hugh Henry, subsequently commissioned a national 
investigation into all drug related deaths in Scotland for the year 
2003. 
 
The aims of the National Investigation were: 
 
• To collect and analyse information relating to the clinical and 
social circumstances surrounding all drug related deaths in 
Scotland for the period January to December 2003; 
 
• To identify patterns in social and clinical circumstances 
surrounding the deaths, and associations between them; and 
 
• To make recommendations for policy and practice that may 
lead to a future reduction in drug related deaths. 
 
Chapter 7 of the National Investigation Report (see Appendix B) 
reviewed the findings from each individual chapter and drew 
together a final set of conclusions along with associated implications 
for service commissioners and providers.  These were drawn from 
the ‘key points’ sections of each chapter.  
 
The Association of Drug Action Teams Drug Related Deaths 
Working Group  
 
The remit of the DAT Working Group was to: 
 
• Support the sharing of information across local Drug and 
Alcohol Action Teams (DAATs) on strategies to prevent drug 
related deaths; 
 
• Identify relevant local initiatives currently being advanced by 
DAATs and to explore common themes and issues; 
 
• Make recommendations on future information sharing 
arrangements across DAATs; and 
 
• Make recommendations on key initiatives that DAATs and 
other partner bodies might wish to consider advancing. 
 
The importance of co-ordinated action on reducing drug related 
deaths is a primary concern for all DAATs in Scotland.  DAATs were 
tasked (through national targets) to reverse the upward trend in 
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drug related deaths and to ensure a reduction of the total number 
of deaths by at least 25% by 2005. 
 
In order to support continued action and thinking on the best 
mechanisms to reduce drug related deaths, a short-life working 
group was convened as a priority area out of the DAT Associations’ 
2003-2004 annual work plan.  
 
The DAT Working Group Report developed two sets of 
recommendations (See Appendix C).  These cover Action Team and 
Local Services, and National Strategy, Co-ordination and 
Communications. 
 
Developments since publication of DAT Working Group 
Report 
 
It should be noted that two of the recommendations from the DAT 
Working Group Report have now been actioned: 
 
• Article 4 of The Medicines for Human Use (Prescribing) 
(Miscellaneous Amendments) Order 2005 (SI 2005 No 1507), 
added Naloxone to the list of medicines, in Article 7 of the 
Prescription Only Medicines (POM) Order, that may be 
administered parentally by any person in an emergency.  This 
change means that Naloxone can now be administered by 
‘any person’ in an emergency to save life.  
 
• The Scottish Executive in association with the Scottish Drugs 
Forum (SDF) announced that a multidisciplinary conference 
‘Taking Action on Scotland’s Drug Related Deaths’ will take 
place in Glasgow on 8th August 2005.  
 
 
SACDM Short-Life Working Group 
 
In drawing together a common set of recommendations and action 
points for the Scottish Executive the SACDM Working Group 
focussed mainly on common themes and issues from both of the 
above reports. However, it nevertheless endeavoured to keep sight 
of some individual, but none the less important issues.  Where 
possible, we have cross-referenced each recommendation and set of 
action points, to comments from the two above reports. 
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It was possible to draw some key messages from both reports.  
 
These are that: 
 
• There is a lack of uniformity across services in how drug 
related deaths are reported. It is difficult to identify the 
population and any reported changes in trends may not be 
valid unless the population is known.  
 
• The National Investigation found that it was difficult to 
identify and extract good quality information from patients’ 
clinical records. At times the information contained in patients’ 
notes was of poor quality or there was poor recording of data.  
 
• In many instances ‘case files’ relating to victims were held by 
generic services, which sometimes did not have effective 
methods for dealing with them or of recognising the 
importance of information that was contained within them. 
 
• Some of the assessments and treatments available from 
specialist services were not evidence based and offered a 
limited range of options. 
 
• The quality of prescribing varied across the country as did 
access to supervised consumption places in pharmacies and 
access to a number of other essential services e.g. medical 
assessment (both in general practice and in specialist 
services). 
 
• Not all services that deal with drug users delivered 
comprehensive harm reduction messages. 
 
• Both reports highlighted the need for increased training and 
awareness raising for everyone including drug service 
personnel, health professionals, ambulance and police service 
personnel, prison officers and staff, drug users, their peers, 
friends, families and carers. 
 
• Both reports highlight the urgent need for joined up working, 
and the importance of exchanging and sharing information 
between agencies and services whilst taking account of issues 
relating to confidentiality. 
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2. Recommendations and Action Points 
 
These are drawn from both the conclusions, implications and key 
findings of National Investigation into Drug Related Deaths in 
Scotland and the recommendations of the DAT Working Group.  
 
In developing the recommendations and action points below, the 
SACDM Working Group recognised that these will only be achieved 
if the required support is available to fund them and take them 
forward. 
 
The SACDM Working Group suggests that the advice of service 
users is sought before taking forward and implementing these 
recommendations.  
 
2.1 Improving responses to overdoses 
 
Raising awareness 
 
The DAT Working Group identified injection and polydrug misuse as 
key factors in drug related deaths. The National Investigation found 
that the detection of benzodiazepines was the most common 
toxicological finding. Few cases were positive for psychostimulants, 
in particular cocaine. In Scotland, the predominant drugs found at 
the time of death were heroin/morphine, benzodiazepines and 
alcohol. 
 
Training for carers, friends and users 
 
The National Investigation found that there were missed 
opportunities to intervene and save the lives of many of the people 
who died. Less than half of those present at the incident had tried 
Cardio-Pulmonary Resuscitation (CPR) and in most cases they had 
died by the time the ambulance arrived.  
 
In those cases where a witness was present the most frequent 
intervention attempted was CPR, followed by various inappropriate 
combinations of slapping, using cold water or showering. 
Worryingly, no intervention was attempted by those witnesses 
present in nearly 40% of cases. Working group members welcomed 
the change to the Medicines Act that makes it possible for ‘any 
person’ to administer Naloxone in an emergency to save life. 
However, the Investigation Team recommends that those in a 
position to administer Naloxone should receive appropriate training 
and that steps are in place to ensure that increased availability does 
not lead to a false sense of security among those administering it 
or, indeed, among drug users themselves. 
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The SACDM Working Group believes that there is an urgent need to 
raise the awareness of drug users, their families, friends, carers, 
and of generic staff most likely to come into contact with them, on 
the dangers of mixing drugs, and in particular the dangers 
associated with mixing opiates, benzodiazepines and alcohol. 
 
Recommendation 1 
 
The Scottish Executive and DAATs should consider methods to raise 
the level of resuscitation skills among drug users, family members, 
friends, and social networks. It is recommended that the provision 
of information and training for families and friends of drug users 
and drug users themselves is further developed across Scotland. 
 
 
Suggested Points for Action 
 
• Scottish Executive to commission the development of a range 
of materials aimed at raising awareness among target groups 
of the causes of drug related death (to include leaflets, 
posters and computer based information), which can be 
customised for local use. 
 
• The Scottish Drugs Forum to further develop and roll out the 
training of drug users, their families and friends to take 
appropriate action in response to a suspected drug overdose. 
 
• DAATs and their NHS Board, Social Work and voluntary sector 
partners to make information about the dangers of mixing 
drugs and alcohol available to drug users from a range of 
outlets such as support groups, services, general practitioners 
(GPs) and community pharmacies. 
 
• DAATs to ensure that the specific targeting of the non-
injecting drug using population is undertaken in their areas. 
 
• Drug services to provide training on basic resuscitation and 
life support techniques to drug misusers, their families and 
friends as part of their core service provision. 
 
Scottish Police Service 
 
The Association of Chief Police Officers in Scotland (ACPOS) is the 
body that decides the national strategies and policies, which give 
direction to the work of the police service in Scotland, including the 
Scottish forces and the Scottish Drug Enforcement Agency (SDEA). 
 
The National Investigation found that the police were in attendance 
at 90% of the scenes of the overdose following a call, in most cases 
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where it was known, from either the ambulance service (18%), or a 
friend or acquaintance (16%). At the scene the police undertook no 
activity in 87% of cases, in 5% of cases they were called to obtain 
access to the overdosed person e.g. force entry through a locked 
door, and in 10 cases police performed CPR. 
 
Perceived Barriers to Contacting Emergency Services 
 
The National Investigation report examined the experience of 
overdose survivors, and found that fear of the police, and, in 
particular, fear of being arrested and blamed if the person died, was 
identified as the greatest barrier. This concern often resulted in 
Injecting Drug Users (IDUs) either not reporting the overdose or not 
staying to help the overdose victim. One hostel dweller claimed ‘a 
lot of people die because others don’t want to go downstairs [in the 
hostel] and say “he’s overdosed” ’.  
 
The National Investigation also found that in nearly half (48%) of 
cases, others were present in the vicinity of the overdose event.  
The period of time that had elapsed between overdose and death 
for most cases investigated was several hours or more (50%), or 
within an hour (14%).  At some (unrecorded) point in time after the 
overdose became known to others, an ambulance was eventually 
called to the scene in 82% of cases.  In 81% of these cases, the 
person was already dead by the time the ambulance arrived. 
 
Since October 2003, a Memorandum of Understanding (MOU) 
between ACPOS and the Scottish Ambulance Service has been in 
place. This seeks to ensure that the police service is contacted by 
the ambulance service when a call is received regarding an 
overdose of controlled drugs.  
 
Recommendation 2 
 
ACPOS and the Scottish Executive should jointly explore ways in 
which contact with the police can be used as an opportunity to 
intervene with vulnerable individuals in order to prevent future drug 
related deaths. In particular, the MOU between ACPOS and the 
Scottish Ambulance Service should be reviewed in order to ensure 
that, in the event of an overdose, help is available as quickly as 
possible. The police attending the scene of an overdose should 
ensure that preservation of life should take precedence.  
 
 
Suggested Points for Action 
 
• The memorandum of understanding between ACPOS and the 
Scottish Ambulance Service to be reviewed and any changes 
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to be clearly communicated in order to ensure, that in the 
event of an overdose, help is available as quickly as possible. 
 
• Contact to be made with Greater Manchester Police to obtain 
information on scheme in place in the Greater Manchester 
area. 
 
 Need for further research 
 
In 2000, the SACDM Research sub-group produced a report that 
looked at research that could inform practice more directly.  This 
report highlighted in particular that research should: 
 
• Provide practical guidance and information for practitioners. 
 
• Give priority to qualitative research that improves 
understanding. 
 
Members of the DAT Working Group considered that on a number of 
occasions the impact of the current ACPOS and Scottish Ambulance 
Service protocol on responding to drug-related overdoses, or 
suspected overdoses led to delays in an ambulance being called.  
DAT Working Group members noted that a legal dilemma might 
exist in some instances in that the Lord Advocate’s guidelines state 
that all deaths are to be treated as a potential culpable homicide 
and the Scottish police are duty-bound to investigate.  
 
As highlighted above, a joint protocol between ACPOS and the 
Scottish Ambulance Service currently requires that the police are 
notified and attend the scene of an overdose.  The DAT Working 
Group suggested that consideration should be given as to whether 
automatic involvement of the police might, in some instances, delay 
witnesses calling for an ambulance. During the course of its 
deliberations, the SACDM Working Group was made aware of some 
preliminary work being undertaken with focus groups by the SDF in 
an attempt to investigate this matter. 
 
Recommendation 3 
 
The Scottish Executive should commission applied research to 
explore drug user perceptions, and those of their friends/family, 
with a view to understanding how delays in contacting the 
emergency services can be reduced. 
 
 
Suggested Points for Action 
 
• The Scottish Executive to commission in-depth applied 
research to identify whether the existing MOU between the 
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police and ambulance service is in fact a barrier to witnesses 
calling emergency services to attend suspected drug 
overdoses. 
 
• Research to be undertaken to identify the perceptions of drug 
users and those of their friends and family to automatic 
attendance by police at suspected drug overdoses, building on 
preliminary investigation undertaken by SDF with focus 
groups.  
 
• The findings from this research to build on the preliminary 
investigation undertaken by SDF with focus groups and used 
to address impact of perceptions and improve emergency 
service responses to drug related deaths. 
 
• Proposed Local Critical Incident Sub Groups to monitor impact 
of ACPOS/Scottish Ambulance Service Memorandum on time 
taken by witnesses to call ambulances to drug overdose or 
suspected overdose. 
 
2.2  Improving the quality of existing responses 
 
The National Investigation found those in contact with specialist 
services were mainly accessing medical treatment (such as the 
prescription of methadone) or Social Work interventions.  However, 
only 17% of those known to services were in receipt of a substitute 
prescription service at the time of death.  
 
The investigators found that prescribed medical treatments were 
not always delivered in keeping with national guidance and 
accepted quality standards. Particular concerns related to 
methadone prescribing and dispensing standards, the prescribing of 
long-term opiate analgesics and benzodiazepines, and the illicit 
availability of prescribed medications. There was also evidence of 
little contact with support or counselling for those in receipt of 
substitute prescribing. 
 
It is essential that the Scottish Executive (through DAATs, NHS 
Boards and professional bodies/Royal Colleges) is in a position to 
ensure that the delivery of all medical treatments for substance 
misuse or prescription of drugs that have abuse potential, is 
evidence based and practised to the highest standards, in line with 
national guidance. All substitute prescribing must be subject to 
audit and clinical governance processes. Progress could be reported 
through the DAAT Corporate Action Plans (CAPs) or the NHS 
accountability process. 
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Ensuring evidence based practice 
 
There is a strong evidence base which supports the view that there 
is a relationship between dose and outcome in methadone 
prescribing, with higher doses being associated with better clinical 
and harm reduction outcomes. Good practice is for methadone 
prescribing to be delivered alongside various psychosocial or 
counselling interventions; an approach which the researchers 
suggest has also been associated with better outcomes. One area of 
concern to the SACDM Working Group was the apparently low level 
of prescribing of high dose buprenorphine (Subutex®) in Scotland 
compared to England and Wales. 
 
Quality and quantity of prescribing in Primary Care 
 
The SACDM Working Group was concerned to learn of anecdotal 
reports of an apparent reduction of GPs’ involvement in Shared Care 
Schemes following the introduction in April 2004 of the new NHS 
General Medical Service Contract (nGMS). In theory nGMS 
introduces an incentive scheme for practices to provide care to drug 
misusers. It is for NHS Boards, in discussion and negotiation with 
local primary care providers, to determine the service that best 
meets local needs. 
 
Both the nGMS and the proposed new community pharmacy 
contract (nGPS) have the potential to add significant resources to 
the treatment of substance misuse. These give NHS Boards and 
their partners an opportunity to create a contractual framework that 
is geared towards improving the quality of care delivered to 
substance misusers in Scotland.   
 
Recommendation 4 
 
NHS Boards and their primary care management components 
should be encouraged to employ the nGMS and nGPS frameworks to 
increase access to high quality, evidence based treatment 
programmes for substance misusers. 
 
 
Suggested Points for Action 
 
• The new GP contractual process to be maximised as a means 
to promote change. 
 
• The new Pharmacy contract should be seen as an opportunity 
to increase the number of supervised consumption places 
available in community pharmacies. 
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New and Innovative Treatments 
 
All substance misusers in Scotland must have rapid access to the 
full range of treatment options appropriate to meet their needs. 
New or more innovative treatments such as high dose 
buprenorphine or diamorphine prescribing may allow some who 
cannot successfully use methadone treatment programmes, to 
remove themselves from the dangers of illicit drug use. However, 
the introduction of such programmes must be co-ordinated to 
maximise impact and care must be taken to ensure the capacity of 
the methadone programme is not threatened by diversion of 
resources. 
 
There is an increasing body of evidence on what can impact on 
reducing drug related harm including drug related deaths. It is 
crucially important that Scotland takes note of this evidence and 
does not take a blinkered view. For instance, the use of other opiate 
substitute medications, such as Subutex®, should be actively 
explored.  There is evidence from France and Australia to suggest 
that the introduction of Subutex® has made a significant 
contribution to the reduction of drug related deaths. 
 
The DAT Working Group considered that, whilst limitation on time 
meant that they had been unable to form any clear views, there 
were reports from elsewhere of new initiatives that might help form 
part of a Scottish strategy for preventing drug related deaths. They 
suggested that these could include the use of safer injecting rooms 
targeted at high-risk homeless individuals, heroin prescribing and 
the provision of greater outreach services to older and more 
vulnerable drug users. It is interesting to note that the World Health 
Organisation (WHO) has recently added both methadone and 
buprenorphine to its Essential Drugs List. 
 
Recommendation 5 
 
The Scottish Executive should develop and fund a co-ordinated 
process of introduction and evaluation of new or more innovative 
treatments across Scotland, with the aim of ensuring that substance 
misusers in all DAAT areas have access to a range of evidence 
based treatments. 
 
 
Suggested Points for Action 
 
• The Scottish Executive to confirm evidence that the increasing 
use of high dose Buprenorphine in France and elsewhere is 
associated with a substantial decline in drug related deaths. 
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• The Scottish Executive should continue to monitor ‘heroin 
pilots’ taking place in England. 
 
• The Scottish Executive to closely monitor developments taking 
place outwith Scotland such as supervised consumption 
rooms. 
 
2.3  Developing existing approaches 
 
The National Investigation found that the majority of those who 
died of drug-related causes in Scotland in 2003 were known to at 
least one service, with some known to several. The victims had 
mainly accessed generic service providers and the services they had 
accessed tended to reflect local service distribution.  Services were 
often accessed in an ad hoc, chaotic manner. Most of the victims 
had been discharged with inadequate follow up in place or they had 
failed to attend any such follow up appointments, resulting in 
discharge and no further action. 
 
The action plan resulting from the Scottish Executive’s Review of 
Drug Treatment and Rehabilitation Services (October 2004) set out 
a series of steps aimed at improving service quality and 
consistency.  As part of that process, future funding to DAATs will 
be distributed, after negotiation, through Performance Contracts, 
awarded on the basis of improvements in performance against 
agreed targets. 
 
Out of Hours Services 
 
The National Investigation found that a higher proportion of 
methadone compared to heroin/morphine-related deaths in 
Scotland occurred at the weekend (defined as Friday to Sunday). 
The SACDM Working Group agreed that it is essential that out of 
hours services are developed so that those experiencing crisis 
outwith service providers normal working hours have access to 
appropriate help and support. 
 
Retention rates and outreach 
 
There is a strong evidence base to support the view that better 
outcomes are observed when people are retained in treatment. A 
high proportion of those who died in 2003 were not in treatment, 
but had had prior contact with a range of agencies before dropping 
out of contact.  It is clear that there is potential to improve 
retention rates. One model would be for agencies (particularly 
specialist services) to follow up those with whom they have lost 
contact, as this group is clearly at greater risk of overdose. It would 
also be advantageous if the Scottish Executive were to require 
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DAATs to report on retention rates and on measures they have put 
in place to improve them. 
 
Recommendation 6 
 
The Scottish Executive should require DAATs and their partners to 
demonstrate that services are delivered in an effective and co-
ordinated way with the aim of delivering clear evidence based 
outcomes, including improved engagement with drug users, 
reduction in waiting times and improvements in retention rates with 
services.  
 
 
Suggested Points for Action 
 
• The Scottish Executive to commission appropriate support to 
DAATs in order to assist them to identify the level of retention 
in treatment and to highlight measures that could be put in 
place to improve them. 
 
• DAATs to create new ways of engaging with those drug users 
who are not currently using treatment services. 
 
• DAATs to explore ways of ensuring services are available 
outside normal working hours and in diverse locations. 
 
• The above recommendation to be monitored through the new 
performance enhanced contractual process involving DAATs 
and the Scottish Executive. 
 
2.4  Targeting those at greatest risk 
 
System to identify those at risk of overdose 
 
The SACDM Working Group was concerned about the impact on the 
homeless and roofless of significant life events such as Christmas, 
Hogmanay, Birthdays and Anniversaries, bereavements and loss of 
contact with children and families. It is essential that effective 
linkages are made between the CAPs, local authority homelessness 
strategies and health and homelessness action plans, in order to 
ensure that the needs of problem drug users, resident in 
hostels/residential accommodation are effectively addressed. One 
means of addressing this problem would be for DAATs and 
Transitory Accommodation providers to develop joint systems to 
identify quickly those problem drug users living in hostels and 
transitory accommodation who are particularly vulnerable.  
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Co-morbidity and people with complex needs 
 
There is increasing evidence to suggest increased rates of 
psychiatric disorders among those people involved in heavy drinking 
and drug taking. The Departments’ of Health Clinical Guidelines 
states that approximately one-third of heavy drinkers have 
associated mental health problems and one-half of dependent drug 
takers have mental health problems of varying severity. These 
problems can result in poorer outcomes with greater levels of 
psychiatric hospitalisation and potential for overdose. 
 
Offenders moving through the criminal justice system 
 
The key to preventing drug deaths on release from prison is to 
ensure continuity of care. This is an important aspect both for 
treatment and integrated care. To ensure that improvements are 
made in this area there has to be more ‘joined up’ thinking in terms 
of continuity and standardisation of treatment practices for 
prisoners on entry to the prison service, as they transfer through 
the service, and on release back into the community. It is essential 
that this level of clinical intervention is needs and not resource led. 
 
In is important that all prisoners on admission to the Scottish Prison 
Service (SPS), who require clinical intervention support, have 
access to continuity of care. Similarly, for all prisoners on liberation, 
who require continuity of treatment, this must be made available by 
the receiving DAAT’s prescribing clinicians.  
 
Services for the Homeless 
 
The National Investigation found that at the time of death few of 
the study population were noted as street homeless in the fiscal 
files (<2%) although another 35 cases (12%) were in temporary 
housing at the time of their deaths. 
 
The DAT Working Group suggested that homeless service staff and 
homeless people should be considered as a ‘high priority’ for 
emergency intervention training. They proposed that for staff this 
should improve recording of and investigation of non-fatal 
overdoses, rapid access to addiction services and the development 
of appropriate accommodation options (with support).  
 
Services for those over thirty 
 
The National Investigation found that drug related deaths increased 
at a significantly higher rate among those aged 35-54 compared to 
15-24 years during 1996-2003. Those who have had a drug 
problem for over ten, and perhaps for as long as twenty years, are 
more likely to have significant health problems than those who have 
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a shorter history of drug use.  This can put them at a higher risk of 
overdose than those who have used drugs for less time. The over 
thirties, perhaps due to their own recognition of their potential to 
die as a result of overdose, can be surprisingly motivated to change 
their behaviour. 
 
Recommendation 7 
 
The Scottish Executive should review services for groups where 
drug related deaths occur at a higher rate than the overall 
population of problem drug users (people recently released from 
prison, the homeless/roofless, people with co-morbidity and 
complex needs, and the over thirties) with the aim of developing 
services and responses that are specifically targeted at these 
vulnerable populations. 
 
 
Suggested Points for Action 
 
For those at greatest risk of overdose, and those complex 
needs i.e. co-morbidity 
 
• DAATs and Transitory Accommodation providers to develop 
systems jointly that will identify quickly problem drug users in 
hostels and transitory accommodation who are particularly 
vulnerable. 
 
• The Scottish Executive to review services for groups where 
drug related deaths occur at a higher rate than the overall 
population of problem drug users (the homeless and/or older 
injectors, those with complex needs i.e. co-morbidity) to 
ensure that services are accessible to these populations. 
 
• Link through proposed Critical Incident Groups, e.g. 
identification of traumatic experiences such as having a child 
taken into care or suffering bereavement. 
 
For Prisoners 
 
• The SPS to increase the number of Addiction Nurses employed 
to improve the level of continuity of care and carers both 
within the prison and on release into the community. 
 
• The SPS to work in partnership with DAATs to ensure that 
medical services, both inside and outside prison, work closely 
together to develop integrated care pathways which ensure 
that on admission to and release from prison, there is 
continuity of care, and where appropriate, access to substitute 
prescribing and supervised dispensing. 
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• The SPS to develop the range of clinical treatments available 
to prisoners, shifting the balance from detoxification to 
stabilisation.  
 
• On release from prison all problem drug users to receive 
effective throughcare. The proposal within the new 
Throughcare Addiction Service arrangement, that short-term 
prisoners (those serving less than 31 days) cannot access 
addictions throughcare support, to be reviewed as a matter of 
urgency. 
 
• The SPS to work in partnership with DAATs to improve the 
range of support services for prisoners, that are released from 
custody on Fridays and require support at weekends, and for 
those where the risk of relapse on release is thought to be 
very high, consideration to be given to the re-introduction of a 
substitute prescription prior to release. 
 
• The SPS and the SDEA to consider formalising existing 
information sharing on drug related deaths in Scotland with a 
view to identifying trends and gaps in service provision within 
prisons and on release into the community. 
 
For the Homeless 
 
• The Scottish Executive to issue guidance to the relevant 
planning groups in order to ensure an appropriate response. 
 
• DAATs to ensure sufficient capacity building support is 
available to transitory accommodation providers to improve 
responses. 
 
• In line with the Homelessness Task Force recommendation 
that supported accommodation places should be made 
available as an alternative to hostel accommodation. 
 
For the over thirties 
 
• Consideration to be given on how to enhance service cover for 
the over thirties. 
 
• The proposed local Critical Incidents Sub-Groups to decide 
how to take this action point forward. 
 
• Existing local Critical Incident Sub-Groups to share experience 
for basis for terms of reference of proposed groups. 
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Reducing supply 
 
The National Investigation found that benzodiazepines were the 
most common drugs detected in drug-related deaths.  Very few 
cases were found to be positive for psychostimulants. The 
researchers noted that the widespread ingestion of 
benzodiazepines, in particular diazepam is a matter of great 
concern. The findings also suggest that illicit manufacture and/or 
diversion of prescribed drugs is a substantial source of drugs for 
users, and remains a significant issue for health service providers 
and others in the field.  
 
Recommendation 8 
 
ACPOS, DAATs and NHS Boards should consider how best to 
address the issue of illicit manufacture and/or diversion of 
prescribed drugs such as benzodiazepines and dihydrocodeine, 
given their prominence in the drug related deaths examined by the 
National Investigation.  
 
 
Suggested Points for Action  
 
• The SDEA to continue the collation of trend information and 
research into illegal supply of POMs, whether licitly or illicitly 
manufactured.   
 
• Focus to be on: 
 
• Licit prescription drugs entering the illicit market via 
diversion from prescription; 
 
• Licit prescription drugs entering the illicit market at 
source (e.g. via Internet sales); 
 
• Counterfeit prescription drugs being manufactured 
illegally and entering the illicit market. 
 
• DAATs and their NHS Board partners to address specific 
issues relating to the prescribing of benzodiazepines and 
opiates.  
 
• Guidance published in the British National Formulary (BNF) 
and the Departments’ of Health guidelines on clinical 
management of drug misuse and dependence to be promoted 
as best practice. 
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2.5  Service Integration, Recording and Information 
Sharing 
 
Better standardised assessments 
 
The National Investigation found that information currently collected 
across Scotland on the social circumstances of victims prior to their 
deaths was sparse, inconsistent and difficult to cross reference. This 
made it difficult for the Investigation Team to explore fully factors 
that might increase or reduce risk of drug related death. The 
SACDM Working Group was concerned to note that not all areas are 
utilising the meaningful process of Single Shared Assessment (SSA) 
that is described in the Effective Interventions Unit (EIU) 
publication, ‘Integrated Care for Drug Users, Principles and Practice’ 
(EIU 2002).  
 
Improved recording in clients’ notes/files 
 
The National Investigation team highlighted the need to improve 
the quality of clinical note keeping in order to allow closer scrutiny 
of the care received by victims.  They found that the information 
contained in patients’ notes was of poor quality and that most case 
files were held by generic services, which sometimes did not have 
effective methods for dealing with them.  
 
Sharing of information 
 
Both the National Investigation and the DAT Working Group reports 
highlighted the lack of uniformity across services in how drug 
related deaths are defined and reported. The DAT Working Group 
suggested that local services should develop a database containing 
known details and service contacts of those who died, to be used to 
improve risk assessment and inform service improvements that 
avoid breakdowns in care pathways. 
 
The National Investigation found that most people suffering drug 
related deaths were known to services and many were accessing 
more than one of these at the same time. The services were often 
generic (i.e. not specialists in the field of substance misuse) and 
were often accessed in an ad hoc, chaotic manner. Most people 
were discharged with inadequate follow up in place or they failed to 
attend any such follow up appointments resulting in their discharge 
from the service and no further action being taken. 
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Recommendation 9 
 
Priority must be given to greater development of the Single Shared 
Assessment as highlighted by the EIU in ‘Integrated Care for Drug 
Users, Principles and Practice’; improving and standardising clinical 
note taking; and developing effective methods for dealing with 
clients’ case files across Scotland. To support these efforts, it is 
essential that robust systems for sharing of information between 
local generic, specific and voluntary services are developed as a 
matter of urgency. 
 
 
Suggested Points for Action 
 
For Single Shared Assessment 
 
• The Scottish Executive to reinforce the importance of services 
using Single Shared Assessments (SSAs). 
 
• EIU work on SSAs to be developed further with the aim of 
setting standards and a time frame for the roll-out of a simple 
to use SSA process for all substance misusers in Scotland. 
 
• Local areas to introduce the use of SSA as a priority and 
ensure that all staff are trained in their use. 
 
To improve recording in clients’ notes/files 
 
• Priority to be given to improving and standardising clinical 
note taking and effective methods for dealing with case files. 
 
• DAATs to ensure, through their health, social work and 
voluntary sector partners, the standardisation of information 
collected by all services which are commissioned in their area 
(in line with Joint Futures, SSAs and Integrated Care). 
 
• A database of details and service contacts of those who died 
to be maintained and used to improve risk assessment and 
inform services in order to avoid breakdowns in care 
pathways.  
 
For information sharing 
 
• DAATs and their partners to encourage service users to agree 
to the introduction of systems that will allow the sharing of 
relevant information about them between services in order to 
improve their safety. 
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• The prevalence intervention developed by the three Grampian 
DAATs should be used as a model of good practice across 
Scotland 
 
2.6  Training for service professionals, staff and the 
voluntary sector 
 
Both the National Investigation and the DAT Working Group reports 
mentioned the importance of staff training as a means of reducing 
drug related deaths. In addition, the National Investigation found 
that only a minority of those who died had accessed medical 
interventions prior to their death. When medical care was accessed 
the intervention provided was often the prescription of methadone. 
The quality of methadone prescribing was often outside that 
contained in the national prescribing guidance (Departments’ of 
Health 1999).  
 
Recommendation 10 
 
The NHS in Scotland and relevant partners (e.g. Royal Colleges and 
academic institutions) should consider supporting the development 
of a national process to promote good practice in the delivery of 
medical treatment to drug misusers. This should include availability 
of a comprehensive range of accredited training (Scottish Training 
on Drugs and Alcohol (STRADA)), The Royal College of General 
Practitioners (RCGP); and the development of meaningful 
prescribing guidance, such as a (Scottish Intercollegiate Guidelines 
Network (SIGN) guideline); and the creation of clinical governance 
(managed care) networks. 
 
 
Suggested Points for Action 
 
• Access to validated training in relation to the management of 
substance misuse in primary care must be made freely 
available to all Scottish GPs, pharmacists and nurses working 
in the field of substance misuse, this to include agreed local 
standards and clinical audit, overseen by local clinical 
governance processes. 
 
Health Care Practitioners Working within the Scottish Prison 
Service  
 
The University of Nottingham has been running a Diploma in Prison 
Medicine since the late 1990s. The course is accredited by the Royal 
Colleges of Physicians, General Practitioners and Psychiatrists 
Examinations Steering Committee.  In late 2004 the RCGP 
announced the launch of a universal programme in prison medicine. 
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The RCGP is linking with the University of Lincoln to convert the 
RCGP Diploma in Prison Medicine into a multidisciplinary Masters 
programme. Recently the Scottish Executive made funding available 
for 60 GPs, 20 pharmacists and 20 nurses in Scotland to undertake 
Part 2 of the RCGP Certificate in the Management of Drug Misuse in 
Primary Care.  It would be helpful if SPS Prison Medical Officers had 
the opportunity to undertake the courses in prison medicine and 
drug misuse.  
 
Critical Incident and Resuscitation Awareness within Prisons 
 
The National Investigation suggested that there is a need to ensure 
that all opportunities are taken to intervene when drug users are in 
prison. As well as improving access to treatment within the prison 
environment, it is also essential that prison staff are competent to 
deal with drug related incidents that occur in the prison setting. 
 
Recommendation 11 
 
Resources should be made available to allow prison medical and 
nursing staff to undertake the RCGP Certificates in the Management 
of Drug Misuse in Primary Care and the Universities of Nottingham 
and Lincoln Prison Medicine programmes. In addition, the Scottish 
Prison Service in conjunction with the Scottish Drugs Forum should 
adapt critical incident resuscitation awareness training for use 
within the prison setting.  
 
 
Suggested Points for Action 
 
• SPS to establish links with relevant external organisations to 
promote the development of resuscitation awareness training 
for staff and prisoners. 
 
• SPS to develop substance misuse information, using a range 
of media, for prisoners on admission, during sentence and 
pre-release.  This to include the dangers to reduced tolerance 
to drugs and alcohol, injecting, inhalation and oral use of 
drugs. 
 
Raising  awareness and Improving co-ordination 
 
The National Investigation noted that there is a need to increase 
awareness of those in contact with drug misusers as most of those 
who died were known to services and many were accessing more 
than one service at the time of their death. 
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Recommendation 12 
 
Training aimed at raising awareness and improving co-ordination of 
activity for those generic staff most likely to come into contact with 
people vulnerable to overdose should be provided as a matter of 
urgency. 
 
 
Suggested Points for Action 
 
• Training of generic staff to be reviewed with a view to 
establishing a standard for training that is aimed at raising 
their awareness of drug related deaths and improving activity 
to reduce prevalence in all relevant disciplines.  
 
2.7  Planning and co-ordination of response 
 
Local Planning 
 
The DAT Working Group found that whilst it is evident that all 
DAATs have in some way considered the issue of how to reduce 
drug related deaths, the actual development of detailed local 
strategies (e.g. Critical Incidents Groups or similar mechanisms) 
has been less widespread.  Valuable examples of developments in 
several areas are given in the report. In particular the Ayrshire and 
Arran model is a good working example that other areas might wish 
to adopt in the establishment of similar working groups. 
 
Recommendation 13 
 
Under the auspices of the Drug and Alcohol Action Teams each area 
should establish a local standing drug deaths monitoring and 
prevention group that involves key agencies in order to manage 
rapid sharing of information on near misses, deaths and street drug 
trends, to instigate action and report on progress in implementing 
proposals to reduce deaths. 
  
 
Suggested Points for Action 
 
• The Scottish Executive will require each DAAT to establish a 
local standing drug deaths monitoring and prevention group, 
which has representation from Accident and Emergency 
(A&E), DAAT drug co-ordinator, local police drug co-ordinator, 
Fiscal’s office etc. 
 
• A significant event and/or critical incident review should be 
undertaken locally following every drug related death, 
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whether the death occurs in primary or specialist care. The 
review should aim to include all professionals who are 
involved in the care of the patient. 
 
• Improved liaison between agencies to be assisted by 
maintenance of database that contains details and service 
contacts on those who died.  
 
• The Ayrshire and Arran Alcohol and Drug Team’s Death 
Review Group to be used as an example of good practice. 
 
2.8  Monitoring Drug Related Deaths 
 
Both the “Scottish Confidential Inquiry into Methadone Related 
Deaths of 2001 (Scott, Jay et al 1999)” and the National 
Investigation comprehensively and systematically examined the 
circumstances of death of those dying of drug related causes during 
the relevant periods of investigation.  Both provided valuable 
information on the causes of death and have highlighted areas for 
improvement in services.  
 
The National Investigation and its analysis demonstrated important 
differences between victims of drug related deaths in Scotland when 
compared to London. One key question posed by the investigators 
is, “to what extent the differences follow and are due to, the 
underlying trends and patterns of drug use in Scotland?” Or, “are 
there differences in the availability and delivery of treatment, and 
investigation of drug related deaths, that may have a bearing on 
mortality statistics and mortality rate in Scotland?” The 
investigators proposed that other studies would be required to test 
potential explanations and hypotheses for these differences. 
 
Definition of drug related death 
 
The National Investigation found that the definition of a ‘drug 
related death’ is not straightforward. It advised that a useful 
discussion on the definition or the definitional problems may be 
found in an article in the Office for National Statistics (ONS) 
publication ‘Population Trends’. In its 2000 report, ‘Reducing Drug 
Related Deaths’ (ACMD 2000), the ACMD considered current 
systems used in the United Kingdom to collect and analyse data on 
drug related deaths. The ACMD recommended that a ‘short life 
technical working group should be brought together to reach 
agreement on a consistent coding framework to be used in future 
across England, Wales, Scotland and Northern Ireland’. General 
Register Office for Scotland (GROS) was represented on the 
resultant group. 
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The ONS ‘standard’ definition essentially relates to deaths related  
to drug poisoning.  It looks at the underlying cause of death 
according to the International Classification of Diseases (ICD) 
criteria.  It is the broadest of the official definitions, covering 
anything from heroin to aspirin to volatile substances. 
 
The UK Drug Strategy definition is somewhat narrower, e.g. 
excluding non-opioid analgesics.  This definition looks at both the 
underlying cause in terms of ICD codes and the status of the drug 
i.e. controlled under the Misuse of Drugs Act 1971. 
 
Both ONS and GROS now use this UK Drug Strategy definition as 
their main definition on official publications on drug related death 
statistics. 
 
It is important to ensure that whoever is collecting the data has as 
broad a definition as possible  so that all three requirements, plus 
any others which are needed at a national (e.g. Scottish) or regional 
or local level can be catered for.  This enables ONS, GROS and the 
National Programme on Substance Abuse Deaths (np-SAD) to 
provide data on a range of sub-samples. 
 
The National Investigation presented its information on drug related 
deaths using this approach. Further details of that can be found in 
Appendix 1 of the National Investigation’s report (Substance Misuse 
Research 2005). 
 
Recommendation 14 
 
The definition of a drug related death must be standardised 
nationwide with the same definition being used by all involved in its 
investigation. For instance, a drug related death could be defined as 
any death, at any age group, that is directly or indirectly related to 
the use of controlled substances. This would include accidental, 
suicidal, homicidal deaths, including those in the very young and in 
older age groups and excludes deaths from overdoses of other 
medicinal drugs. This definition would trawl all deaths from 
benzodiazepines.  
 
 
Suggested Points for Action 
 
• UK Drug Strategy definition of drug related death to be widely 
disseminated and used throughout Scotland. 
 
Establishment of National Confidential Inquiry 
 
In its report the DAT Working Group proposed that a national 
steering group should be developed with a remit to look at how 
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recommendations from the ACMD ‘Reducing Drug Related Deaths’ 
report and the findings of the National Investigation could best be 
implemented across Scotland.  
 
Members of the SACDM Working Group were very impressed by the 
“Confidential Inquiry” process and were strongly of the opinion that 
such a process should be used routinely for the investigation of drug 
related deaths in Scotland. Experience gained from the National 
Investigation, the Glasgow Confidential Inquiry into Methadone 
Related Deaths of 1996, the Scottish Confidential Inquiry of 2001, 
and the np-SAD, based at St George’s Hospital, London, could all be 
used as examples of good practice. 
 
We propose that consideration should be given to the introduction 
of an ongoing National Confidential Inquiry into Drug Related 
Deaths in Scotland. 
 
Recommendation 15 
 
A National ‘Preventing Drug Related Deaths Forum’ should be 
established with a remit to report to Ministers annually on trends 
and causes of drug related deaths in Scotland.   
 
 
Suggested Points for Action 
 
• As a priority the Scottish Executive, through the SACDM 
‘Preventing Drug Related Deaths Forum’, should develop a 
minimum data set to be collected in all cases of drug related 
death in Scotland.  This dataset to be comprehensive and in 
line with other UK and European monitoring systems (e.g. the 
European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA)). 
 
• The Scottish Executive to establish a National Confidential 
Inquiry into Drug Related Deaths under the auspices of the 
proposed  ‘Preventing Drug Related Deaths Forum’. 
 
• The National Confidential Inquiry to collate drug related death  
data and perform detailed comparisons of trends to increase 
availability of valuable information on local and national 
indicators of risk factors.  
 
• Experience gained from the National Investigation, the 1996 
Glasgow Confidential Inquiry into Methadone Related Deaths; 
the 2001 Scottish Confidential Inquiry; and np-SAD all to be 
used as examples of good practice. 
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2.9  Toxicological findings and circumstances of 
death 
 
Interpretation of Toxicology 
 
The National Investigation’s researchers found that the mean blood 
morphine and methadone concentrations recorded in most cases of 
drug related death were significantly lower in Scotland compared to 
London. The Researchers suggested that it was unclear whether this 
factor reflects a true difference in consumption patterns and 
prescription dosage, or differences in the toxicological testing 
between sites. Mean alcohol concentration was higher in the 
Scottish sample, but this finding did not explain any difference in 
the mean heroin concentration between Scotland and London. 
 
Recommendation 16 
 
In order to enable a long term, meaningful interpretation of post-
mortem toxicological data, Procurators Fiscal, who instruct 
autopsies on these deaths, should insist that the pathologists 
carrying out the autopsies follow a nationally agreed protocol based 
on an agreed best practice model. 
 
 
Suggested points for action 
 
• A nationally agreed protocol based on an agreed good practice 
model to be developed and disseminated to pathologists who 
carry out drug related deaths autopsies.  
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 Appendix B 
 
 
National Investigation into Drug Related Deaths, 
2003 
 
Chapter 7: Conclusions and Implications 
 
What is in this chapter? This chapter reviews the findings from individual chapters 
and draws together a final set of conclusions along with associated implications for 
service commissioners and providers. 
 
Where did the information come from? The information has been drawn from the 
“key points” sections from each chapter in the body of the report 
 
 
 
Introduction 
 
This investigation has comprehensively examined the circumstances of death, social 
circumstances and service contacts of those dying as a result of a drug-related death in 
Scotland in 2003. It has also considered long-term trends in drug-related death in 
Scotland and has compared the circumstances of the 2003 Scottish deaths with data 
from a concurrent study into drug-related deaths in London for the same year. Finally 
the investigation has compared service utilisation characteristics of a group of living 
injecting drug users with a sub-sample of deaths drawn from the same geographical 
area and has explored the opinions, beliefs and knowledge of living injectors 
regarding overdose risk.  
 
The developing evidence-base implies that many drug-related deaths may be 
preventable and this investigation aimed to identify areas which, if effectively 
addressed would impact on the rate of drug-related deaths in Scotland. 
 
Each chapter of the report has therefore identified “Key Points” based on the data 
collected. These are summarised below and, with the exception of chapter 2, have 
been used to generate implications for service commissioners and providers arising 
from the findings of this investigation. 
 
Describing the study population and trends over time 
 
Most Scottish drug related deaths in 2003 were male, in their early 30s (mean age of 
32.8 years), living at home in a house or flat, often with others, and were long-term or 
dependent drug users. These findings indicate that very few cases were homeless 
single drug users. Most were considered to have been accidental drug overdoses 
(based on ICD-10 criteria for drug related deaths), although a sizeable 13% were 
classified as suicides. These characteristics are consistent with previous published 
studies into drug related deaths.   
Trends in drug-related deaths in Scotland from 1996 to 2003 were complex and 
showed a great deal of heterogeneity over time in relation to geographical 
distribution and the involvement of heroin/morphine or methadone. Drug-related 
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deaths involving heroin/morphine had increased at a significantly higher rate than 
those involving methadone in Scotland during 1996-2003 (13.8% vs –0.4% per 
year, respectively). In Glasgow, however, deaths involving heroin (which 
increased at an average 6.5% per year) increased at a higher rate than those 
involving methadone (increasing with an average rate of 9.7% per year).  
Drug-related deaths involving heroin/morphine had increased at a significantly 
higher rate out-with the main urban centres of Glasgow and Lothian during 1996-
2003, and likely relates to the growth of drug use in these areas. Overall, there 
were twice as many deaths involving heroin/morphine as methadone. However, 
the ratio of heroin/morphine : methadone overdose deaths varied considerably 
between geographical areas – for example, from 117 : 26 in Lanarkshire to 21 : 
70 in Tayside and 59 : 175 in Lothian. These differences should be investigated 
further. 
A higher proportion of methadone compared to heroin/morphine–related deaths 
in Scotland occurred at the weekend (defined as Friday to Sunday) and may be 
associated with non-supervised prescribing of methadone at the weekend. 
The finding that drug-related deaths in Scotland, including those involving either 
heroin/morphine or methadone, have increased at a significantly higher rate among 
those aged 35-54 compared to 15-24 years during 1996-2003 could be attributed to an 
ageing population of drug users. 
 
Toxicological findings and circumstances of death 
 
1. There were missed opportunities to intervene and save the lives of many of the 
people who died. Less than half had tried CPR and most cases had died by the time 
the ambulance arrived.  
 
Implications 
 
There is a need to develop and deliver training and education for drug users and their 
families to increase awareness of the risks of overdose, how to avoid it, how to 
identify it and how to respond effectively. 
 
2. Benzodiazepines were the most common drugs detected in drug-related deaths. 
Few cases were positive for psychostimulants, in particular cocaine. The predominant 
drugs found at the time of death continue to be heroin/morphine, benzodiazepines and 
alcohol in Scotland. There was a high proportion of cases who did not inject any 
drugs nor use heroin prior to overdose and death. Drug users who do not inject heroin 
are also at risk of fatal drug overdose. Diversion of prescribed drugs is a significant 
problem with nearly half of methadone related deaths, and two-thirds of diazepam and 
dihydrocodeine positive deaths involving illicitly obtained medications. 
 
Implications 
 
There is a need to address prescribing practices in relation to the drugs implicated in 
these deaths – benzodiazepines and oral opiates – much of which is likely to be 
emanating from General Practice. This could be considered under the quality agenda 
within the GP contract. 
 
Services must be aware of the risks of non-injecting drug use and must continue to 
warn drug users and the broader community of the dangers of combinations of drug 
use including alcohol. Drug treatment services may also need to be aware that 
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non-injecting dependent drug (in particular licit drug) and alcohol users, especially 
older users, may not be attracted into seeking help from them because they may not 
identify with their younger, illicit drug using injecting clientele. 
  
3. The same drug-related cause of death may be recorded on the death certificate by 
forensic authorities in various ways.  
 
Implications 
 
Introducing a standardised, uniform nomenclature for recording drug-related deaths 
on medical certificates would improve the monitoring and researching of drug-related 
deaths. Systematic collation and availability of forensic toxicological data would also 
assist the monitoring and analysis of drug use trends in fatalities.  
 
4. London drug related deaths showed broadly similar demographic and 
circumstantial characteristics to those of Scottish deaths but significantly differed 
on toxicological findings – London deaths had a higher proportion of cases 
positive for cocaine, and a lower proportion positive for benzodiazepines and 
dihydrocodeine. Blood drug concentrations also significantly differed with higher 
morphine and methadone levels among the London group and a higher blood 
alcohol concentration in the Scottish group.   
 
Implications 
 
Differences in toxicological characteristics between the two groups raise questions 
about possible differences in prescribing practices of benzodiazepines, 
dihydrocodeine and methadone across London and Scotland, and suggest 
differences in heroin purity and cocaine use between the two regions. 
 
Social circumstances prior to death 
 
1. Information, as it is currently collected across Scotland is sparse, inconsistent and 
difficult to cross-reference.  
 
Implications 
 
Use of a standardised, well-validated method of collecting agreed data on all drug 
deaths would substantially facilitate the identification of relevant social risk factors.  
  
2. The lack of up to date relevant information in many of the casefiles, which would 
be required to organise an integrated care plan is a concern. The availability of rich, 
up to date information would allow identification and prioritisation of potential risk 
factors in this vulnerable population which could reduce future morbidity and 
mortality and must form part of good practice in the management of drug misusers.  
 
Implications 
 
Staff in all settings should be trained to comprehensively and holistically assess drug 
misusers and to ensure that regular updates of essential information (eg regarding 
childcare responsibilities, life events etc.) are recorded. Nationally, standards could be 
set within the DAT Corporate Action Plan requiring recording of adequate 
information. Locally, DATs and their health and Local Authority partners could 
ensure that services are commissioned with clear quality standards and monitoring 
procedures in place. 
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Contact with services 
 
1. Most people who died of drug-related causes were known to services and many 
were accessing more than one. These services were often generic (i.e. not specialists 
in the field of substance misuse) and were often accessed in an ad hoc, chaotic 
manner. Following this contact, most were discharged with inadequate follow up in 
place or failed to attend any such follow up appointments resulting in discharge and 
no further action.   
 
Implications 
 
There is a need to increase awareness of this problem and to deliver training and 
improved coordination of activity for those generic staff most likely to come into 
contact with this group – General Practitioners, Psychiatric services, Accident & 
Emergency and Social Work. 
 
2. Medical interventions were only accessed by a minority. When accessed the 
intervention was often prescribed methadone. Quality of methadone prescribing was 
often outside that contained in national practice guidelines. Few of those prescribed 
methadone were in receipt of any counselling.  
 
Implications 
 
Methadone replacement should be prescribed only in line with the current evidence 
base – following a full assessment of drug problems and dependency; in adequate 
doses to meet need; dispensed safely and effectively under supervision until the 
person is demonstrably stable. Methadone replacement prescribing should be 
delivered alongside supportive counselling. 
 
3. Seventy had been in prison in the last 6 months. Transitional Care is not being 
made available to all who require it. Prisons show varying success regarding take-up 
rates. Ten people died within 3 days of release of which 6 were released on a Friday.  
 
Implications 
 
There is a need to ensure all opportunities are taken to intervene when drug misusers 
are in prison. In particular, there is a need to ensure that effective communication 
takes place so that imprisonment does not interrupt treatment (if in treatment before 
incarceration) or (if not in treatment) that the time in prison gives an opportunity to 
increase access to treatment and reduce risk of overdose. 
 
Interviews with overdose survivors 
 
The majority of overdoses occurred amongst those who had taken more than one 
substance on the day of overdose. Heroin had been taken in all but one overdose. 
Heroin and diazepam taken together or on the same day was the most common 
combination, taken in 22 cases. In fifteen overdoses heroin and diazepam were the 
only drugs consumed; in the remaining five episodes they were taken in combination 
with one or two other substances and/or alcohol. 
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Injecting drug users are aware, to some extent, of the overdose risks, although this 
knowledge is not extensive. Less than half mentioned tolerance as a factor and less 
than half considered that a mixture of drugs could be risky. There were some 
misconceptions about overdose risk factors. Some injecting drug users believed that 
overdose would not occur if heroin was smoked or if it was injected by itself. 
Injecting with someone else present was the most frequently cited prevention strategy. 
 
Inflicting physical pain was the most common intervention used by injecting drug 
users. Although putting the overdose victim into the recovery position was cited by 
half the sample, the infliction of pain was still regarded as the most effective strategy. 
Half of the sample was worried about having another overdose. Among those who 
were not worried, some claimed not to care whether they lived or died. 
 
Implications 
 
There is a need to develop and deliver training and education for drug users and their 
families to increase awareness of the risks of overdose, how to avoid it, how to 
identify it and how to respond. 
 
Conclusion 
 
This investigation has identified a number of implications for services in the 
prevention of future drug-related deaths in Scotland. It has highlighted some 
limitations of fiscal and national registry office data on drug-related mortality 
and has raised aspects of drug-related deaths requiring further research. Finally, 
the report provides some baseline indicators by which the potential effectiveness 
of interventions to prevent or reduce drug related deaths in future might be 
measured. Some of these outcome measures might include improved after care 
from prison, improved delivery of methadone treatment, and increased 
engagement of drug users with services especially drug treatment services.   
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Appendix C 
 
Report of the Association of Drug Action Teams: 
Drug-Related Deaths Working Group 
 
Section 5 
 
Recommendations 
 
Action Team and Local Services Recommendations: 
 
Development of Local Action Team Critical Incidents Groups:  Continued 
improvement in liaison between agencies over drug deaths, e.g. setting up a standing 
drug deaths monitoring and prevention group, involving key agencies to ensure rapid 
sharing of information on deaths/street drug trends, and to report on progress in 
implementing proposals to reduce deaths. 
 
Database development: Local services should develop a database containing known 
details and service contacts of those who died, to be used to improve risk assessment 
and inform service improvements that avoid breakdowns in care pathways. 
 
Linkages with Accident & Emergency: All Action Teams should consider the 
experience of the three Grampian Action Teams and review their current relationship 
with Accident & Emergency Departments.  
 
Improving Witness / Emergency Intervention: All Action Teams should consider 
as a priority ways of decreasing delays at the scene of an overdose, and methods for 
raising the level of resuscitation skills among drug users, family members, service 
providers and social networks.  
 
Key to this recommendation is the expanded delivery of local First Aid training, with 
a particular focus on dealing with overdose. Efforts should be directed towards peer 
education, emergency services, and family support groups. Action Teams should 
therefore identify local structures and resources required for advancing training that 
utilises both peer and social support networks. A valuable resource for Action Teams 
in advancing this area will be the new SDF initiative. 
 
Homelessness services staff and homeless people should be considered as high 
priority for emergency intervention training. For staff this should include improved 
recording and investigation of non-fatal overdoses, rapid access to addiction services, 
and development of appropriate accommodation options (with support). 
 
Best Practice in the use of Naloxone:  Local Critical Incidents Groups or other 
similar structures should consider the benefits, particularly within ‘hot spots’, of the 
extended use of Naloxone. 
 
Staff Training: A resource pack (including ‘Know The Score’ materials and wider 
training presentations) should be developed to assist local addiction managers in 
familiarising staff with good overdose prevention practice. Such training should form 
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part of a rolling programme. Coupled with this, steps should be taken to emphasise 
overdose prevention training as part of local training strategies. 
 
 
Association of Drug Action Teams Recommendations: 
 
Amendment to the Medicines Act:  
 
The Association of Drug Action Teams should consider recommending an 
amendment to the use of the Medicines Act that would place Naloxone on the ‘safe’ 
list for general administration. Such a change would create the opportunity, for those 
areas that wish to do so, to proceed with local fatal overdose prevention pilots to 
include the use of Naloxone. 
 
National Strategy, Co-ordination and Communications: 
 
National “Preventing Drug-Related Deaths” Forum:  
  
A national steering group to be developed, with a remit to look at how 
recommendations from the ACMD ‘Reducing Drug-Related Deaths’ report and 
findings of National Investigation can be best implemented across Scotland. 
Representation should include police, prison, Scottish Ambulance Service, Accident 
& Emergency departments, Action Teams, and relevant service sectors.  This group 
should look at wider initiatives such as safer injecting rooms and heroin prescription, 
and how such initiatives might reduce drug-related deaths. 
 
National Communications / “Know The Score”:  
 
It is recommended that an updated overdose related publication of ‘Know The Score’ 
is published and addresses the issue of ‘scene of crime’ versus ‘medical emergency’.  
 
National Conference 
 
Members recommend that during 2005 a multi-disciplinary conference on reducing 
drug-related deaths be hosted by the Scottish Executive. Such an event should draw 
on the experiences of this working group together with the findings from the national 
investigation. 
Appendix D 
 
List of Recommendations 
 
1. The Scottish Executive and DAATs should consider methods to 
raise the level of resuscitation skills among drug users, family 
members, friends, and social networks. It is recommended that the 
provision of information and training for families and friends of drug 
users and drug users themselves is further developed across 
Scotland. 
 
2. ACPOS and the Scottish Executive should jointly explore ways 
in which contact with the police can be used as an opportunity to 
intervene with vulnerable individuals in order to prevent future drug 
related deaths. In particular, the MOU between ACPOS and the 
Scottish Ambulance Service should be reviewed in order to ensure 
that, in the event of an overdose, help is available as quickly as 
possible. The police attending the scene of an overdose should 
ensure that preservation of life should take precedence.  
 
3. The Scottish Executive should commission applied research to 
explore drug user perceptions, and those of their friends/family, 
with a view to understanding how delays in contacting the 
emergency services can be reduced. 
 
4. NHS Boards and their primary care management components 
should be encouraged to employ the nGMS and nGPS frameworks to 
increase access to high quality, evidence based treatment 
programmes for substance misusers. 
 
5. The Scottish Executive should develop and fund a co-
ordinated process of introduction and evaluation of new or more 
innovative treatments across Scotland, with the aim of ensuring 
that substance misusers in all DAAT areas have access to a range of 
evidence based treatments. 
 
6. The Scottish Executive should require DAATs and their 
partners to demonstrate that services are delivered in an effective 
and co-ordinated way with the aim of delivering clear evidence 
based outcomes, including improved engagement with drug users, 
reduction in waiting times and improvements in retention rates with 
services.  
 
7. The Scottish Executive should review services for groups 
where drug related deaths occur at a higher rate than the overall 
population of problem drug users (people recently released from 
prison, the homeless/roofless, people with co-morbidity and 
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complex needs, and the over thirties) with the aim of developing 
services and responses that are specifically targeted at these 
vulnerable populations. 
 
8. ACPOS, DAATs and NHS Boards should consider how best to 
address the issue of illicit manufacture and/or diversion of 
prescribed drugs such as benzodiazepines and dihydrocodeine, 
given their prominence in the drug related deaths examined by the 
National Investigation.  
 
9. Priority must be given to greater development of the Single 
Shared Assessment (SSA) as highlighted by the EIU in ‘Integrated 
Care for Drug Users, Principles and Practice’; improving and 
standardising clinical note taking; and developing effective methods 
for dealing with clients’ case files across Scotland. To support these 
efforts, it is essential that robust systems for sharing of information 
between local generic, specific and voluntary services are developed 
as a matter of urgency. 
 
10. The NHS in Scotland and relevant partners (e.g. Royal 
Colleges and academic institutions) should consider supporting the 
development of a national process to promote good practice in the 
delivery of medical treatment to drug misusers. This should include 
availability of a comprehensive range of accredited training 
(Scottish Training on Drugs and Alcohol (STRADA)), The Royal 
College of General Practitioners (RCGP); and the development of 
meaningful prescribing guidance, such as a (Scottish Intercollegiate 
Guidelines Network (SIGN) guideline); and the creation of clinical 
governance (managed care) networks. 
 
11. Resources should be made available to allow prison medical 
and nursing staff to undertake the RCGP Certificates in the 
Management of Drug Misuse in Primary Care and the Universities of 
Nottingham and Lincoln Prison Medicine programmes. In addition, 
the SPS in conjunction with the SDF should adapt critical incident 
resuscitation awareness training for use within the prison setting.  
 
12. Training aimed at raising awareness and improving co-
ordination of activity for those generic staff most likely to come into 
contact with people vulnerable to overdose should be provided as a 
matter of urgency. 
 
13. Under the auspices of the DAATs each area should establish a 
local standing drug deaths monitoring and prevention group that 
involves key agencies in order to manage rapid sharing of 
information on near misses, deaths and street drug trends, to 
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instigate action and report on progress in implementing proposals to 
reduce deaths. 
 
14. The definition of a drug related death must be standardised 
nationwide with the same definition being used by all involved in its 
investigation. For instance, a drug related death could be defined as 
any death, at any age group, that is directly or indirectly related to 
the use of controlled substances. This would include accidental, 
suicidal, homicidal deaths, including those in the very young and in 
older age groups and excludes deaths from overdoses of other 
medicinal drugs. This definition would trawl all deaths from 
benzodiazepines.  
 
15. A National ‘Preventing Drug Related Deaths Forum’ should be 
established with a remit to report to Ministers annually on trends 
and causes of drug related deaths in Scotland.  
 
16. In order to enable a long term, meaningful interpretation of 
post-mortem toxicological data, Procurators Fiscal, who instruct 
autopsies on these deaths, should insist that the pathologists 
carrying out the autopsies follow a nationally agreed protocol based 
on an agreed best practice model. 
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Appendix E 
Glossary of Terms 
 
ACMD   Advisory Council on the Misuse 
of Drugs 
 
ACPOS   Association of Chief Police 
Officers in Scotland 
 
A&E  Accident and Emergency 
Departments of hospitals 
 
Autopsy   (post-mortem examination) – a 
comprehensive investigation of 
the body of a deceased person, 
carried out by a pathologist. It 
includes and external and 
internal examination of all body 
systems as well as the taking of 
specimens for a laboratory 
analysis 
 
Benzodiazepines Tranquillisers (depressants) e.g. 
diazepam, temazepam or 
nitrazepam 
 
BNF British National Formulary 
 
CAP  Corporate Action Plan 
 
Case Files/Notes   Comprehensive dossier 
maintained for each individual 
patient/client, which contains all 
the written documents relating 
to the care of a patient/client, 
including the results of 
specialised investigations and 
any tests that have been carried 
out. Family doctors and hospital 
doctors keep a file of each 
patient separately, other 
agencies, such as social work 
and drugs services, also 
maintain separate files. 
 
CD Controlled Drugs 
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Co-morbidity Co-existence of mental illness, 
drug and/or alcohol misuse. 
 
 
Confidential Inquiry  An anonymous general; scrutiny 
by a multidisciplinary panel of 
medical and other experts of the 
clinical and autopsy documents 
relating to a death with the 
scope of; a) discovering if the 
death was preventable; b) if 
changes in care are required; 
and c) if changes in the manner 
of investigation of the death are 
required. Confidential Inquiries 
publish annual reports. 
 
CPR   Cardio-pulmonary Resuscitation 
 
DAAT         Drug and Alcohol Action Team 
 
DAT Working Group   Association of Drug and Alcohol 
Action Teams’ Short-life 
Information Sharing Sub-group 
 
Departments’ of Health Health Departments in Scotland, 
England, Wales and Northern 
Ireland 
  
EIU   Effective Interventions Unit 
 
EMCDDA European Monitoring Centre for 
Drugs and Drug Addiction – 
collects, analyses and 
disseminates objective, reliable 
and comparable information on 
drugs and drug addiction in the 
European Union. 
 
Generic Services  Non-specialist services e.g. 
General Practice, Community 
Pharmacy. 
 
Generic Staff  GPs, pharmacists, Accident and 
Emergency staff, Social Work 
staff, Acute Psychiatric Services 
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GP General Practitioner 
 
GROS   General Register Office for 
Scotland 
 
ICD International Classification of 
Diseases 
 
IDU(s) Intravenous Drug Users(s) 
 
Integrated Care Pathways Combines and co-ordinates all 
the services required to meet the 
assessed needs of the individual. 
 
MO  Medical Officer 
 
MOU   Memorandum of Understanding 
 
nGMS   NHS General Medical Services 
Contract 
 
nGPS  NHS General Pharmaceutical 
Services Contract 
 
NHS Board Organisation responsible for the 
strategic planning of health 
services and measures to 
improve the health of the 
community in their region. 
 
np-SAD  National Programme on 
Substance Abuse Deaths 
 
ONS  Office for National Statistics 
 
Psychostimulants Stimulant drugs (uppers) e.g. 
cocaine or amphetamine 
 
POM   Prescription Only Medicine 
 
Primary Care Practitioner   General Practitioner, Practice 
Nurse, Community Pharmacist 
 
Royal Colleges Royal College of Psychiatrists, 
Royal College of Physicians, 
Royal College of General 
Practitioners,  
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Royal Pharmaceutical Society of 
GB,  
Royal College of Nursing etc. 
 
SACDM Scottish Advisory Committee on  
Drug Misuse 
 
SDEA Scottish Drugs Enforcement 
Agency 
 
SDF Scottish Drugs Forum 
 
SCS Shared Care Scheme 
 
SIGN Scottish Intercollegiate 
Guidelines Network. SIGN is an 
independent body that publishes 
guidelines which are subject to 
regular revisions. The Guidelines 
are developed after wide 
consultation with specific experts 
from the Royal Colleges in 
Scotland together with other 
experts in the field with the 
scope of listing evidence based 
best practice guidelines to assist 
those treatment particular 
conditions. 
 
SMR Substance Misuse Research 
 
SMR 24/SMR 25 Forms used to record data for 
the Scottish Drug Misuse 
Database 
 
Specialist Services Dedicated drug services 
 
SPS Scottish Prison Service 
 
SSA Single Shared Assessment – 
aims to create a single point of 
entry to community care services 
with a view to better use of 
resources and more effective 
outcomes for people in need. 
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STRADA 
 
Scottish Training on Drugs and 
Alcohol: aims to improve the 
skills of professional staff who 
address drug and alcohol 
misuse. 
 
Subutex® Brand name for Buprenorphine 
 
WHO World Health Organisation 
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